Our Brand

click

Asclepius Meditec's Brand Philosophy

In July 2008, Hsin-Yung Lin, a veteran of over 30 years in the medical device components industry, was diagnosed with advanced gastric and nasopharyngeal cancer following a major gastrointestinal bleeding. Between 2008 and 2011, he underwent conventional treatment including chemotherapy, radiotherapy, and surgery, leading to his weight dropping from 90 kg to 65 kg, and quality of life deteriorating significantly.

On March 11, 2011, following the devastating earthquake and tsunami in Japan, Lin was deeply inspired by the philosophy of philanthropist Cheng Yen of Taiwan’s Tzu Chi Foundation. Motivated by this guidance, he donated his life savings and personally joined recovery efforts in the hardest-hit areas of Miyagi Prefecture, despite the risks of nuclear radiation exposure.During this period of close contact with the Japanese civilians, he was introduced to emerging research on the health benefits of hydrogen gas. He quickly realized that achieving a therapeutically effective dose required far more hydrogen than what could be provided through hydrogen-rich water alone. (For context: inhaling 3 liters of hydrogen gas per minute is equivalent to consuming 10 metric tons of hydrogen water.)

Combining hydrogen and oxygen gases posed a significant technical challenge due to the risk of explosion. Striking the right balance between therapeutic efficacy and safety became the driving force behind Asclepius Meditec’s innovation. Today, this pursuit has led to the granting of over 500 global patents. The motivation behind Lin’s story stemmed from a pressing truth: while the risk of explosion was uncertain, the threat of illness was inevitable, and action had to be taken.

Currently, less than 1% of the global population is aware that water-derived hydrogen hold therapeutic potential. We invite you to help us share this story—and help bring the future of hydrogen-oxygen therapy to more people.
asclepius meditec's brand philosophy

Key figures as of May 9, 2025:

16

Multi-center Human Clinical

16

Single-center Human Clinical

300+

Basic Research Projects

102

SCI paper publication

459

Innovation utility-design patents

The Hydronaut

To the visionaries dedicating themselves to planetary ecology and human health, we present this cosmic journey through hydrogen, humanity, and healing.

How vast is the universe? To this day, we have no answer.

In this infinite cosmos, Earth's presence is smaller than a grain of sand at your feet...Hydrogen constitutes over 90% of cosmic matter it fuels starlight and solar fire through nuclear fusion. Yet among countless celestial bodies, oxygen exists only in Earth's fragile biosphere. When hydrogen met oxygen, water was born... and with water, all terrestrial life.

Asclepius Meditec stands as humanity's pioneer in unlocking water's (H₂O) therapeutic potential. By reverting it to inhalable hydrogen-oxygen gas, we've created a revolutionary therapy for chronic inflammatory diseases across nine physiological systems (including oncology). Our extensive evidence-based research suggests this innovation may alter the 6,000-year trajectory of medical science!Who could have imagined? The alchemy of water and organic nutrients reveals nature's profound answer to our timeless quest: how to prevent disease, mitigate illness, and reduce healthcare burdens.

This is nature's ultimate gift to humankind where reverence for life meets scientific revelation, and where science transcends into philosophy. Whether you embrace it or not, its absolute biosafety is incontestable. Let us together receive this dawn of a new medical paradigm.

Founder of HydroNourish Therapy
Lin Hsin-Yung

Corporate Promotional Video

This documentary presents a comprehensive overview of Asclepius Meditec’s mission, development journey, and key milestones from 2011 to 2025.

When a cancer patient discovered the groundbreaking potential of hydrogen-oxygen in life sciences, he did not rush to commercialize it, but rather devoted the next 14 years to focusing on just two things:

1. Product Development
Asclepius Meditec has committed to designing and manufacturing a hydrogen-oxygen nebulizer that is environmentally sustainable, biocompatible, non-toxic, and clinically effective. To date, the company has filed over 500 utility patents worldwide, with 315 granted. It has also obtained two official Class III medical device approvals from national regulatory authorities—the only such approvals globally to date.

2. Medical Research
In collaboration with 21 academicians from the Chinese Academy of Sciences and Chinese Academy of Engineering, and more than 1,000 clinicians across China's top 100 hospitals, Asclepius Meditec has conducted over 300 preclinical studies and 32 human clinical trials. A total of 97 medical research papers have been published, demonstrating the scientific validity of our product.

These two foundational initiatives have taken 14 years to achieve and we are not stopping here; these efforts will be carried forward with strengthened commitment. For the Asclepius Meditec team, this is more than a mission—it's a belief in the future of life sciences.

Building on this foundation, we now begin our third initiative—comprising three key goals:
   1. Raise global awareness: Share accurate information with the 8 billion people across the globe that hydrogen-oxygen therapy has been substantiated by research and demonstrates measurable efficacy.
   2. Invite partnerships: Collaborate with organisations in the healthcare and medical sectors to bring this innovation to those who need it most.
   3. Advance hydrogen-nutritional therapy: Co-develop and optimize the clinical applications of “HydroNourish Therapy” with the world’s leading nutraceutical R D teams.

As the first company in the world to discover that inhaling hydrogen-oxygen mixed gas combined with organic nutrition can help restore weakened cellular function, ultimately enabling disease prevention and therapeutic intervention, we put forward the following insights:

1. Root Causes of Cellular Damage
Modern lifestyles generate an excess of harmful reactive oxygen species (e.g., hydroxyl radicals and peroxynitrite) from chronic stress, electromagnetic radiation, unhealthy habits, environmental pollution, drug toxicity, and viral infections. These free radicals damage mitochondrial function, impairing the body’s ability to efficiently produce ATP (cellular energy).

2. Nutritional Imbalance
Overprocessing, genetic modification, and excessive use of fertilizers and hormones in agriculture have led to an overconsumption of macronutrients (proteins, fats, carbohydrates), while the essential organic micronutrients found in naturally grown fruits, vegetables, and meats, such as trace minerals, vitamins, and polyphenols, are increasingly lacking, resulting in widespread nutritional imbalance.

We invite global teams working on nutritional science to join us in this mission to make a difference together.

— The Asclepius Medical Research Team

Fulfilling Our Mission in the Fight Against the COVID-19 Pandemic

During the COVID-19 pandemic, Asclepius Meditec donated over 3,000 hydrogen-oxygen nebulizers as part of humanitarian contribution to countries including China, Vietnam, Cambodia, Russia, India, Kazakhstan, Malaysia, and Thailand — with a total estimated value exceeding USD 30 million. These contributions played a meaningful role in global pandemic response efforts and were widely recognized by the international community.

Governments from multiple recipient countries later issued official letters of appreciation, acknowledging our support. The initiative was was recognized and commended by leading national media, including Xinhua News Agency, People’s Daily, China Central Television (CCTV), and Jiefang Daily.

Following the pandemic, Asclepius Meditec was invited to attend recognition events held by the Ministry of Industry and Information Technology and various provincial governments, where it received commendations and official letters of gratitude.

Academician Zhong Nanshan

Professor Zhong Nanshan was the first respiratory physician in China to be elected to the Chinese Academy of Engineering. His leadership during both the 2003 SARS outbreak and the 2020 COVID-19 pandemic has been credited with saving countless lives. For his contributions, he has received widespread recognition from the United Nations and government leaders around the world. Widely regarded as one of the most prominent international figures in pulmonology of the 21st century, Professor Zhong also served as President of the Chinese Medical Association, the country’s largest professional body for physicians.

Professor Zhong was the first to lead the Asclepius Meditec clinical research team in launching clinical trials. With his guidance and endorsement, numerous physicians and specialists from China’s top 100 hospitals (out of more than 30,000 nationwide) have adopted Asclepius Meditec’s hydrogen–oxygen therapy in basic research and clinical studies across the nine major systems of the human body, particularly in chronic disease management.

The remarks featured in the video were delivered by Professor Zhong at the launch event ofHydrogen for Cancer Control , a published collection of real-world clinical cases documenting hydrogen–oxygen therapy in 82 patients with advanced-stage cancer.
click